Roe DJ - Search Results

1

Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.

Jacobs ET, Haussler MR, Alberts DS, Kohler LN, Lance P, Martínez ME, Roe DJ, Jurutka PW. Jacobs ET, et al. Among authors: roe dj. Cancer Prev Res (Phila). 2016 Jul;9(7):589-97. doi: 10.1158/1940-6207.CAPR-16-0033. Epub 2016 May 2. Cancer Prev Res (Phila). 2016. PMID: 27138789 Free PMC article. Clinical Trial.

2

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.

Taylor CW, Alberts DS, Peng YM, McCloskey TM, Matzner M, Roe DJ, Plezia PM, Grindey GB, Hamilton M, Seitz D. Taylor CW, et al. Among authors: roe dj. J Natl Cancer Inst. 1992 Dec 2;84(23):1798-802. doi: 10.1093/jnci/84.23.1798. J Natl Cancer Inst. 1992. PMID: 1433369 Clinical Trial.

3

Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial.

Alberts DS, Mason-Liddil N, Plezia PM, Roe DJ, Dorr RT, Struck RF, Phillips JG. Alberts DS, et al. Among authors: roe dj. J Natl Cancer Inst. 1991 Dec 4;83(23):1739-42. doi: 10.1093/jnci/83.23.1739. J Natl Cancer Inst. 1991. PMID: 1770553 Clinical Trial.

4

Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Taylor CW, Alberts DS, Ketcham MA, Satterlee WG, Holdsworth MT, Plezia PM, Peng YM, McCloskey TM, Roe DJ, Hamilton M, et al. Taylor CW, et al. Among authors: roe dj. J Clin Oncol. 1989 Nov;7(11):1733-40. doi: 10.1200/JCO.1989.7.11.1733. J Clin Oncol. 1989. PMID: 2809686

5

Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.

Alberts DS, Surwit EA, Peng YM, McCloskey T, Rivest R, Graham V, McDonald L, Roe D. Alberts DS, et al. Cancer Res. 1988 Oct 15;48(20):5874-7. Cancer Res. 1988. PMID: 3167842

6

Predictive model for plasma concentration-versus-time profiles of investigational anticancer drugs in patients.

Davis LE, Alberts DS, Plezia PM, Roe DJ, Griswold DP. Davis LE, et al. Among authors: roe dj. J Natl Cancer Inst. 1988 Aug 3;80(11):815-9. doi: 10.1093/jnci/80.11.815. J Natl Cancer Inst. 1988. PMID: 3392741

7

Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial.

Struck RF, Alberts DS, Horne K, Phillips JG, Peng YM, Roe DJ. Struck RF, et al. Among authors: roe dj. Cancer Res. 1987 May 15;47(10):2723-6. Cancer Res. 1987. PMID: 3552204 Clinical Trial.

8

Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.

Einspahr J, Alberts D, Xie T, Ritchie J, Earnest D, Hixson L, Powell M, Roe D, Grogan T. Einspahr J, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):359-66. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7655331

9

Validation of proliferation indices as surrogate endpoint biomarkers.

Alberts DS, Einspahr J, Aickin M, Hixson L, Earnest D, Roe D, Powell M. Alberts DS, et al. J Cell Biochem Suppl. 1994;19:76-83. J Cell Biochem Suppl. 1994. PMID: 7823609 Clinical Trial.

10

Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratories.

Roe DJ, Alberts DS, Wargovich MJ, Bostick RM, Garewal HS, Einspahr J, Fosdick L, Ramsey L, Woods C, McGee DL. Roe DJ, et al. Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):349-53. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 9162300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page